Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

288 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Application of the SMALP technology to the isolation of GPCRs from low-yielding cell lines.
Tedesco D, Maj M, Malarczyk P, Cingolani A, Zaffagnini M, Wnorowski A, Czapiński J, Benelli T, Mazzoni R, Bartolini M, Jóźwiak K. Tedesco D, et al. Among authors: cingolani a. Biochim Biophys Acta Biomembr. 2021 Sep 1;1863(9):183641. doi: 10.1016/j.bbamem.2021.183641. Epub 2021 May 10. Biochim Biophys Acta Biomembr. 2021. PMID: 33984320 Free article.
Sex-Specific HLA Alleles Contribute to the Modulation of COVID-19 Severity.
Spartano S, Faggiano MV, Guidi G, D'Ambrosio P, Vaisfeld A, Novelli A, Falqui S, Cingolani A, Lambertenghi L, Visentin A, Azzini A, Righi E, Trecarichi EM, Mazzitelli M, Coletti S, Mous J, Rademacher TW, Torti C, Tacconelli E, Fantoni M, Cauda R, Tiziano FD. Spartano S, et al. Among authors: cingolani a. Int J Mol Sci. 2024 Dec 8;25(23):13198. doi: 10.3390/ijms252313198. Int J Mol Sci. 2024. PMID: 39684907 Free PMC article.
Kinetics of hepatitis B virus replication in anti-HBc positive/HBsAg-negative people with HIV switching to tenofovir sparing therapy.
Salpini R, D'Anna S, Alkhatib M, Piermatteo L, Tavelli A, Benedetti L, Quiros Roldan E, Cingolani A, Papalini C, Carrara S, Malagnino V, Puoti M, Sarmati L, Ceccherini-Silberstein F, Perno CF, Monforte AD, Svicher V. Salpini R, et al. Among authors: cingolani a. Int J Infect Dis. 2025 Jan;150:107294. doi: 10.1016/j.ijid.2024.107294. Epub 2024 Nov 5. Int J Infect Dis. 2025. PMID: 39505254 Free article.
Long-acting injectable antiretrovirals for HIV treatment in the ICONA cohort: physicians' and nurses' points of view.
Cingolani A, Tavelli A, De Benedittis S, Mastrorosa I, Muccini C, Bini T, Carraro A, Compagno M, Mazzitelli M, Guastavigna M, Cernuschi M, Torti C, Antinori A, d'Arminio Monforte A; ICONA Foundation Study group. Cingolani A, et al. J Antimicrob Chemother. 2024 Oct 1;79(10):2662-2667. doi: 10.1093/jac/dkae273. J Antimicrob Chemother. 2024. PMID: 39140512
Real World Use of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis of COVID-19 in Immunocompromised Individuals: Data from the OCTOPUS Study.
Vergori A, Matusali G, Cimini E, Bordi L, Borrelli P, Lanini S, Palazzi R, Paulicelli J, Mariotti D, Mazzotta V, Notari S, Casetti R, Francalancia M, Rosati S, D'Abramo A, Mija C, Mencarini P, Milozzi E, Caraffa E, Sica S, Metafuni E, Sorà F, Rago A, Siniscalchi A, Abruzzese E, Garzia M, Luzi G, Battistini R, Prosperini L, Cingolani A, Girardi E, Maggi F, Antinori A; OCTOPUS Study Group. Vergori A, et al. Among authors: cingolani a. Vaccines (Basel). 2024 Jul 17;12(7):784. doi: 10.3390/vaccines12070784. Vaccines (Basel). 2024. PMID: 39066422 Free PMC article.
288 results